Canon Medical Systems USA has received clearance from the U.S. Food and Drug Administration (FDA) for its Alphenix 4D CT with Aquilion One/Insight Edition interventional imaging system.
The system is a hybrid of the company’s Alphenix 4D CT angiography system and its flagship Aquilion One/Insight Edition CT scanner. The integrated multimodal system is designed for use in interventional radiology and enables diagnosis, planning, treatment, and verification in one room, thereby eliminating the need for patient transfer between departments, according to the firm.
Canon is on schedule to make the system commercially available in the summer of 2026. Alphenix 4D CT with Aquilion One/Insight Edition will be on display at RSNA 2025 in Chicago, the company added.
